MedTrace Logo

Linking Obesity and Estrogen-responsive Genes in Endometrial Cancer

NCT02226302 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16

Last updated 2021-09-09

No results posted yet for this study

Summary

The objective is to develop an organotypic model to assess the effects of obesity on the expression and methylation status of estrogen-responsive genes in endometrial cancer. Omental fat samples will be removed from participants during surgery and these fat samples will be used in laboratory analyses.

Conditions

Sponsors & Collaborators

  • Queensland Institute of Medical Research

    collaborator OTHER

  • Royal Brisbane and Women's Hospital

    collaborator OTHER_GOV

  • Queensland Centre for Gynaecological Cancer

    lead OTHER_GOV

Principal Investigators

  • Donal Brennan · Queensland Health

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2018-05-31
Completion
2021-08-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02226302 on ClinicalTrials.gov